Diameters and Wall-to-lumen Ratio of Retinal Arterioles in Patients With Retinal Vein Occlusion.
NCT01789437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-02-12
Summary
to evaluate the wall-to-lumen ratio (WLR) of retinal arterioles in hypertensive patients with retinal vein occlusion (RVO) before and after dexamethasone intravitreal implant 0.7 mg (DEX) compared to a matched control group of normal eyes in non-hypertensive subjects.
Conditions
- Hypertensive Patients With Retinal Vein Occlusion
Interventions
- DEVICE
-
Dexamethasone Intravitreal Implant (Ozuredex)
Sponsors & Collaborators
-
Università degli Studi di Brescia
lead OTHER
Principal Investigators
-
Andrea Russo, Dr. · University of Brescia, Italy
Study Design
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2012-06-30
- Completion
- 2013-01-31
Countries
- Italy
Study Locations
More Related Trials
-
Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion
NCT02033031 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis
NCT03971279 ·Status: COMPLETED
-
Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
NCT04601701 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
NCT01231633 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration
NCT03680326 ·Status: COMPLETED
-
Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
NCT01568021 ·Status: COMPLETED
-
Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
NCT04067856 ·Status: WITHDRAWN ·Phase: NA
-
Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
NCT04601688 ·Status: UNKNOWN ·Phase: NA
-
Effects of Moxaverine and Placebo on Ocular Blood Flow
NCT00709423 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab
NCT04138420 ·Status: COMPLETED
-
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
NCT01025934 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)
NCT00370760 ·Status: UNKNOWN ·Phase: PHASE3
-
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD
NCT02367365 ·Status: COMPLETED
-
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
NCT02036424 ·Status: COMPLETED ·Phase: PHASE4
-
Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
NCT01309451 ·Status: COMPLETED ·Phase: PHASE4
-
Retinal Vessel Diameter in Branch Retinal Vein Occlusion
NCT02215109 ·Status: COMPLETED
-
Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion
NCT03353324 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
NCT01350323 ·Status: COMPLETED ·Phase: NA
-
Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion
NCT01085734 ·Status: COMPLETED ·Phase: PHASE4
-
Central Vein Occlusion Study (CVOS)
NCT00000131 ·Status: COMPLETED ·Phase: PHASE3
-
Bevacizumab and Long Acting Gas in Diabetic Vitrectomy
NCT00656435 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration
NCT01027468 ·Status: COMPLETED ·Phase: NA
-
NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO Patients
NCT05133791 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
NCT00709657 ·Status: TERMINATED ·Phase: NA
-
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
NCT01471054 ·Status: TERMINATED ·Phase: PHASE2